beta-Lipotropin. Adipozin . beta-LPH . beta-Lipotrophin . beta LPH . beta Lipotrophin . beta Lipotropin . Lipotropin . A 90-amino acid peptide derived from post-translational processing of pro-opiomelanocortin (POMC) in the PITUITARY GLAND and the HYPOTHALAMUS. It is the C-terminal fragment of POMC with lipid-mobilizing activities, such as LIPOLYSIS and steroidogenesis. Depending on the species and the tissue sites, beta-LPH may be further processed to yield active peptides including GAMMA-LIPOTROPIN; BETA-MSH; and ENDORPHINS. . 0.38
Adipocytes. Lipocytes . Adipocyte . Cell, Fat . Cells, Fat . Fat Cell . Lipocyte . Fat Cells . Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. . 0.38
Lipoproteins. Circulating Lipoproteins . Lipoprotein . Lipoproteins, Circulating . Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. . 0.37
Lipotropic Agents. Lipocaic . Lipotropic Drugs . Lipotropics . Agents, Lipotropic . Drugs, Lipotropic . Factors, Lipotropic . Lipotropic Factors . Endogenous factors or drugs that increase the transport and metabolism of LIPIDS including the synthesis of LIPOPROTEINS by the LIVER and their uptake by extrahepatic tissues. . 0.37
Diethylpropion. 2-Diethylaminopropiophenone . Amfepramone . Anorex . Delgamer . Diethylpropion Hydrochloride . Dietil-retard . Ifa Norex . Lipomin . Maruate . Modératan . Neobes . Nobesine . Phepranon . Propion . Préfamone . Regenon . Regibon . Tenuate . Tepanil . Dietil retard . Dietilretard . Hydrochloride, Diethylpropion . Norex, Ifa . Amfepramon . A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290) . 0.37